FDA Inspection 802081 — Merck Serono S.P.A.

Merck Serono S.P.A. — FEI 3003581732

The FDA completed an inspection of Merck Serono S.P.A. on Sep 25, 2012 in Modugno. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 25, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Modugno (Italy)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
139521 CFR 211.103Actual vs. theoretical yields not determined
145121 CFR 211.113(b)Procedures for sterile drug products
163021 CFR 211.130(b)Unlabeled filled containers controls
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.